Have you heard the media say that you can get Mounjaro prescribed by your GP? This is misleading as there is a specific criteria that has been set nationally for the safe roll out of this medication. Here’s an explanation of how it is being prescribed in Primary Care in Cambridgeshire & Peterborough. NHS England and NICE have approved the use of Tirzepatide, which you may also know as Mounjaro®️ or ‘the weight loss drug’, from primary care. You may well hear that Tirzepatide is available from primary care from 23rd June 2025. However, in the first two years entry criteria have been set by NHS England to a very small number of people. This is to allow safe entry of this repurposed medicine into the health system. Please only contact your GP Practice if you have: BMI of 40kg/m2 or above (or 37.5 kg/m2 for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds) AND at least FOUR out of the following five health conditions which have already been diagnosed by your GP or other health professional: Established Type 2 diabetes Hypertension requiring blood pressure lowering therapy Atherosclerotic cardiovascular disease Obstructive sleep apnoea where treatment is indicated i.e. continuous positive airway pressure (CPAP) Dyslipidaemia requiring treatment. If you meet the above criteria, the service will not be provided by GP Practices GP Practices can refer you for assessment to the ‘Healthy You’ service - the provider which has been commissioned locally to manage this service. If ‘Healthy You’ decide you can be prescribed Tirzepatide, the ongoing responsibility of the prescribing and monitoring remains with ‘Healthy You’. More information can be found on the Healthy You website,